GSK Consumer Unit Finds Growth Groove By Innovating, Acquiring, Expanding
This article was originally published in The Rose Sheet
Executive Summary
GlaxoSmithKline's consumer health-care business increased its sales by 8 percent in the firm's latest earnings period, reflecting the firm's "strategy to grow and diversify the business away from a dependency on 'white pill/western markets,'" CEO Andrew Witty noted